Page 968 - Cote clinical veterinary advisor dogs and cats 4th
P. 968

Histiocytic Diseases  475.e1


           ADDITIONAL SUGGESTED                RELATED CLIENT EDUCATION
           READINGS                            SHEETS
  VetBooks.ir  Abadie J, et al: Epidemiology, pathology, and genetics   Consent to Administer Chemotherapy            Diseases and   Disorders
            of histiocytic sarcoma in the Bernese mountain
                                               Consent to Perform Abdominal Ultrasound
            dog breed. J Hered 100(suppl 1):S19-S27, 2009.
           Affolter  VK,  et  al:  Localized  and  disseminated
            histiocytic sarcoma of dendritic cell origin in dogs.   Consent to Perform Bone Marrow Biopsy
                                               Consent  to  Perform  Fine-Needle  Aspiration
            Vet Pathol 39:74-83, 2002.          of Masses
           Affolter VK, et al: Feline progressive histiocytosis.
            Vet Pathol 43(5):646-655, 2006.
           Erich SA, et al: Causes of death and the impact of
            histiocytic sarcoma on the life expectancy of the
            Dutch population of Bernese mountain dogs and
            flat-coated retrievers. Vet J 198(3):678-683, 2013.
           Hafeman S, et al: Evaluation of liposomal clodronate
            for treatment of malignant histiocytosis in dogs.
            Cancer Immunol Immunother 59(3):441-452,
            2010.
           Klahn  S,  et  al:  Evaluation  and  comparison  of
            outcomes in dogs with periarticular and nonperi-
            articular histiocytic sarcoma. J Am Vet Med Assoc
            239(1):90-96, 2011.
           Mariani CL, et al: Histiocytic sarcoma with central
            nervous system involvement in dogs: 19 cases
            (2006-2012).  J  Vet  Intern  Med  29(2):607-613,
            2015.
           Moore AS, et al: Chemotherapy for dogs with lymph
            node metastasis from histiocytic sarcomas. Aust Vet
            J 95(1-2):37-40, 2017.
           Pierezan F, et al: Immunohistochemical expression
            of ionized calcium binding adapter molecule 1 in
            cutaneous histiocytic proliferative, neoplastic and
            inflammatory disorders of dogs and cats. J Comp
            Pathol 151(4):347-351, 2014.
           Ruple A, et al: Risk factors associated with the devel-
            opment of histiocytic sarcoma in Bernese mountain
            dogs. J Vet Intern Med 30(4):1197-1203, 2016.
           Rassnick  KM,  et  al:  Phase  II,  open-label  trial  of
            single-agent  CCNU  in  dogs  with  previously
            untreated histiocytic sarcoma. J Vet Intern Med
            24(6):1528-1531, 2010.
           Skorupski KA, et al: CCNU for the treatment of
            dogs with histiocytic sarcoma. J Vet Intern Med
            21(1):121-126, 2007.
           University of California Davis, School of Veterinary
            Medicine: Canine histiocytosis (website).  www.
            histiocytosis.ucdavis.edu/.
































                                                      www.ExpertConsult.com
   963   964   965   966   967   968   969   970   971   972   973